Tigertriever 13 (blood clot removal device)

2022: Device Announcement

In late July 2022, Rapid Medical introduced the Tigertriever 13 device, designed to remove a blood clot from thin blood vessels in the brain during an ischemic stroke.

Rapid Medical said in a press release that Tigertriever 13 is the smallest revascularization device in the world for July 2022, the device adjusts to the vascular system and blood clot through a more atraumatic approach than existing devices. According to the developers, Tigertriever 13 has adjustment capabilities that existing stent retrievers lack, and the 3D braid is borrowed from recent advances in aerospace engineering.

Device released to remove blood vessel blood clots during ischemic stroke

{{quote 'The neurovascular region has long been waiting for a thrombectomy device designed for small vessels. Drug therapy for July 2022 is suboptimal for these patients, so devices that urgently restore blood flow and at the same time minimize potential harm can be of great benefit, said David Fiorella, a doctor at the University Medical Center. }} Cerebral vascular thrombosis is a disease characterized by the formation of blood clots in the vessels that provide blood supply to the brain. The initial stage of pathology often proceeds in a latent form, and the person does not feel any symptoms. As the disease develops, headaches, nausea, seizures, fever, paralysis of the face and limbs appear. The disease develops against the background of infections, hormonal disorders, head injuries, increased blood clotting.

The device from Rapid Medical is precisely monitored to capture the thrombus and relieve tension from the vascular bed before removal. Thanks to the possibility of adjustment, the device has the lowest profile among all stent retrievers 24% smaller than devices with a diameter of 3 mm, and this facilitates navigation in complex anatomical areas. The ability to tailor each procedure may provide a new level of safety in high-risk thrombectomy.^[1]

Notes